Billing and Coding: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease

This billing/coding guidance applies to reporting the Prostate Cancer Genomic Classifier assay for men with localized prostate cancer (ICD-10-CM C61). Claims must include the applicable CPT code, one unit of service, the appropriate DEX Z-Code adjacent to the CPT code in specified Part A/Part B claim fields or paper form fields, and ICD-10-CM code C61.

"Male patient with localized prostate cancer, diagnosis coded as ICD-10-CM C61, for whom a Prostate Cancer Genomic Classifier assay is being reported."

Sign up to see full coverage criteria, indications, and limitations.